Health Monthly Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.

Press releases published on September 9, 2026

8 hours ago

Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada’s GLP-1 Program

Indeterminate GlobeNewswire

8 hours ago

ImPact Biotech Announces Completion of Treatment in Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC and Positive Regulatory Updates

Indeterminate GlobeNewswire

8 hours ago

Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences

Indeterminate GlobeNewswire

8 hours ago

Parity and Maine RMOMS Partnership Demonstrates New Approach to Strengthening Rural Maternity Care

Indeterminate GlobeNewswire

8 hours ago

H1 Acquires Defacto Health to Strengthen Provider Network Intelligence

Indeterminate GlobeNewswire

8 hours ago

Editas Medicine Reports Inducement Grants to New Chief Medical Officer

Indeterminate GlobeNewswire

8 hours ago

Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio

Indeterminate GlobeNewswire

8 hours ago

Mindera Health Collaborates with the University of Pennsylvania for Academic Research Exploring Cutaneous Lupus Erythematosus Treatment

Indeterminate GlobeNewswire

8 hours ago

SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026

Indeterminate GlobeNewswire

8 hours ago

Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment

Indeterminate GlobeNewswire

8 hours ago

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

Indeterminate GlobeNewswire

8 hours ago

Syncromune® Presents SYNC-T™ Therapy: Image-Guided Cryolysis and Intratumoral Immunotherapy at CIRSE 2026

Indeterminate GlobeNewswire

8 hours ago

Propanc Biopharma to Initiate World-First Phase 1b First-in-Human Study of PRP in February 2027

Indeterminate GlobeNewswire

8 hours ago

Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry

Indeterminate GlobeNewswire

8 hours ago

Trinity Biotech’s Trinovium Subsidiary Signs Contract to Supply Red Team Investments with Advanced Liquid Cooling Solutions for AI Data Center Infrastructure

Indeterminate GlobeNewswire

8 hours ago

ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders

Indeterminate GlobeNewswire

8 hours ago

IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress

Indeterminate GlobeNewswire

9 hours ago

Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

9 hours ago

Monogram Health Publishes Inaugural Impact Report, Documenting Impressive Clinical and Financial Outcomes Resulting From Its In-Home Multispecialty Medical Group Care Model

Indeterminate GlobeNewswire

9 hours ago

Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial

Indeterminate GlobeNewswire